Radiation is associated with tissue damage and increased risk of
atherosclerosis, but there are currently no treatments and a very limited mechanistic understanding of how radiation impacts tissue repair mechanisms. We uncovered that radiation significantly delayed temporal resolution programs that were associated with decreased efferocytosis in vivo.
Resolvin D1 (RvD1), a known proresolving
ligand, promoted swift resolution and restored efferocytosis in sublethally irradiated mice. Irradiated macrophages exhibited several features of senescence, including increased expression of p16INK4A and p21, heightened levels of SA-β-gal, COX-2, several proinflammatory
cytokines/
chemokines, and oxidative stress (OS) in vitro, and when transferred to mice, they exacerbated
inflammation in vivo. Mechanistically, heightened OS in senescent macrophages led to impairment in their ability to carry out efficient efferocytosis, and treatment with RvD1 reduced OS and improved efferocytosis. Sublethally irradiated Ldlr -/- mice exhibited increased plaque
necrosis, p16INK4A cells, and decreased lesional
collagen compared with nonirradiated controls, and treatment with RvD1 significantly reduced
necrosis and increased lesional
collagen. Removal of p16INK4A hematopoietic cells during advanced
atherosclerosis with p16-3MR mice reduced plaque
necrosis and increased production of key intraplaque-resolving mediators. Our results demonstrate that sublethal radiation drives macrophage senescence and efferocytosis defects and suggest that RvD1 may be a new therapeutic strategy to limit radiation-induced tissue damage.